These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 16401625

  • 1. Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis.
    Bledsoe G, Crickman S, Mao J, Xia CF, Murakami H, Chao L, Chao J.
    Nephrol Dial Transplant; 2006 Mar; 21(3):624-33. PubMed ID: 16401625
    [Abstract] [Full Text] [Related]

  • 2. Role of tissue kallikrein in prevention and recovery of gentamicin-induced renal injury.
    Bledsoe G, Shen B, Yao YY, Hagiwara M, Mizell B, Teuton M, Grass D, Chao L, Chao J.
    Toxicol Sci; 2008 Apr; 102(2):433-43. PubMed ID: 18227104
    [Abstract] [Full Text] [Related]

  • 3. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction.
    Chao J, Bledsoe G, Yin H, Chao L.
    Biol Chem; 2006 Jun; 387(6):665-75. PubMed ID: 16800727
    [Abstract] [Full Text] [Related]

  • 4. Kallikrein-kinin in stroke, cardiovascular and renal disease.
    Chao J, Chao L.
    Exp Physiol; 2005 May; 90(3):291-8. PubMed ID: 15653716
    [Abstract] [Full Text] [Related]

  • 5. Tetramethylpyrazine protects rat renal tubular cell apoptosis induced by gentamicin.
    Juan SH, Chen CH, Hsu YH, Hou CC, Chen TH, Lin H, Chu YL, Sue YM.
    Nephrol Dial Transplant; 2007 Mar; 22(3):732-9. PubMed ID: 17132701
    [Abstract] [Full Text] [Related]

  • 6. Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats.
    Xia CF, Bledsoe G, Chao L, Chao J.
    Am J Physiol Renal Physiol; 2005 Sep; 289(3):F622-31. PubMed ID: 15886273
    [Abstract] [Full Text] [Related]

  • 7. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation.
    Li HJ, Yin H, Yao YY, Shen B, Bader M, Chao L, Chao J.
    Cardiovasc Res; 2007 Jan 01; 73(1):130-42. PubMed ID: 17137568
    [Abstract] [Full Text] [Related]

  • 8. Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery.
    Bledsoe G, Shen B, Yao Y, Zhang JJ, Chao L, Chao J.
    Hum Gene Ther; 2006 May 01; 17(5):545-55. PubMed ID: 16716111
    [Abstract] [Full Text] [Related]

  • 9. Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in rats.
    Murakami H, Yayama K, Chao L, Chao J.
    Kidney Int; 1998 May 01; 53(5):1305-13. PubMed ID: 9573546
    [Abstract] [Full Text] [Related]

  • 10. Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction.
    Yao YY, Yin H, Shen B, Chao L, Chao J.
    Regul Pept; 2007 Apr 05; 140(1-2):12-20. PubMed ID: 17196272
    [Abstract] [Full Text] [Related]

  • 11. Diallyl sulfide enhances antioxidants and inhibits inflammation through the activation of Nrf2 against gentamicin-induced nephrotoxicity in Wistar rats.
    Kalayarasan S, Prabhu PN, Sriram N, Manikandan R, Arumugam M, Sudhandiran G.
    Eur J Pharmacol; 2009 Mar 15; 606(1-3):162-71. PubMed ID: 19374873
    [Abstract] [Full Text] [Related]

  • 12. Early activation of bradykinin B2 receptor aggravates reactive oxygen species generation and renal damage in ischemia/reperfusion injury.
    Chiang WC, Chien CT, Lin WW, Lin SL, Chen YM, Lai CF, Wu KD, Chao J, Tsai TJ.
    Free Radic Biol Med; 2006 Oct 15; 41(8):1304-14. PubMed ID: 17015177
    [Abstract] [Full Text] [Related]

  • 13. Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis.
    Xia CF, Yin H, Borlongan CV, Chao L, Chao J.
    Hypertension; 2004 Feb 15; 43(2):452-9. PubMed ID: 14698996
    [Abstract] [Full Text] [Related]

  • 14. Experimental therapy with tissue kallikrein against cerebral ischemia.
    Chao J, Chao L.
    Front Biosci; 2006 May 01; 11():1323-7. PubMed ID: 16368519
    [Abstract] [Full Text] [Related]

  • 15. Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis.
    Xia CF, Yin H, Yao YY, Borlongan CV, Chao L, Chao J.
    Hum Gene Ther; 2006 Feb 01; 17(2):206-19. PubMed ID: 16454654
    [Abstract] [Full Text] [Related]

  • 16. Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction.
    Yao YY, Yin H, Shen B, Chao L, Chao J.
    J Card Fail; 2007 Sep 01; 13(7):588-96. PubMed ID: 17826650
    [Abstract] [Full Text] [Related]

  • 17. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress.
    Zhang JJ, Bledsoe G, Kato K, Chao L, Chao J.
    Kidney Int; 2004 Aug 01; 66(2):722-32. PubMed ID: 15253727
    [Abstract] [Full Text] [Related]

  • 18. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.
    Wolf WC, Yoshida H, Agata J, Chao L, Chao J.
    Kidney Int; 2000 Aug 01; 58(2):730-9. PubMed ID: 10916096
    [Abstract] [Full Text] [Related]

  • 19. Naringin ameliorates gentamicin-induced nephrotoxicity and associated mitochondrial dysfunction, apoptosis and inflammation in rats: possible mechanism of nephroprotection.
    Sahu BD, Tatireddy S, Koneru M, Borkar RM, Kumar JM, Kuncha M, Srinivas R, Shyam Sunder R, Sistla R.
    Toxicol Appl Pharmacol; 2014 May 15; 277(1):8-20. PubMed ID: 24637089
    [Abstract] [Full Text] [Related]

  • 20. The effect of alpha-melanocyte stimulating hormone on gentamicin-induced acute nephrotoxicity in rats.
    Kolgazi M, Arbak S, Alican I.
    J Appl Toxicol; 2007 May 15; 27(2):183-8. PubMed ID: 17216604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.